Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 3, 2018 (9 years ago)

Revlimid 10 mg oral cap NDC 59572-0410-28 28 days supply

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Revlimid 10 mg oral cap NDC 59572-0410-28 28 days supply

Affected NDC 59572-0410-28

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Revlimid
Lenalidomide
NDC 59572-0410
10 mg/1 Capsule
Oral
Celgene Corporation Rx
Recalling firm
Kroger Specialty Pharmacy, Inc.
NDC code
59572-0410-28
Origin
MS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0771-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Kroger Specialty Pharmacy, Inc.

All 2018 recalls

Other cgmp deviation recalls from 2018

All cgmp deviation recalls
Class II · Moderate risk

Oxygen

CGMP Deviations

Terminated cGMP deviation Roberts Home Medical LLC D-1002-2019
Class II · Moderate risk

Cidofovir Dihydrate

CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Terminated cGMP deviation LGM Pharma LLC D-0486-2019